However, VDR activation in non-parenchymal liver cells like Kupffer or hepatic stellate cells could exert anti-inflammatory and anti-fibrotic effects [54], and consequently prevent NAFLD progression to nonalcoholic steatohepatitis and fibrosis. The gene discussed is VDR; the disease is metabolic dysfunction-associated steatohepatitis.